BioCardia Q2 EPS $(0.17) Misses $(0.16) Estimate, Sales $43.00K Miss $120.00K Estimate
Portfolio Pulse from saritha@benzinga.com
BioCardia reported Q2 losses of $(0.17) per share, missing the analyst consensus estimate of $(0.16) by 6.25%. The company's quarterly sales were $43.00K, missing the estimate of $120.00K by 64.17%. This represents a 21.43% decrease in EPS and a 95.59% decrease in sales compared to the same period last year.
August 09, 2023 | 8:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BioCardia's Q2 earnings missed estimates, with a larger than expected loss per share and a significant decrease in sales compared to last year.
BioCardia's Q2 earnings report shows a larger than expected loss per share and a significant decrease in sales compared to the same period last year. This negative financial performance is likely to negatively impact the company's stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100